Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Prorok

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Medical Screening|May 13, 1999
Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modificationP M Marcus, P C Prorok
Gynecologic Oncology|December 1, 1994
NIH Consensus 1994: screeningB S Kramer, J Gohagan, P C Prorok
Journal of Chronic Diseases|January 1, 1981
Concepts and problems in the evaluation of screening programsP C Prorok, B F Hankey, B N Bundy
Journal of Clinical Epidemiology|January 1, 1991
The case-control design and the assessment of the efficacy of cancer screeningR J Connor, P C Prorok, D L Weed
The Urologic Clinics of North America|November 1, 1990
Statistical considerations in cancer screening programsP C Prorok, R J Connor, S G Baker
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Is screening for prostate cancer the current gold standard?--"no"B S Kramer, J K Gohagan, P C Prorok
Statistics in Medicine|February 24, 1999
Estimation of post-lead-time survival under dependence between lead-time and post-lead-time survivalJ L Xu, R M Fagerstrom, P C Prorok
Cancer|January 15, 1993
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancersB S Kramer, J Gohagan, P C Prorok, et al.
American Journal of Epidemiology|June 15, 2000
Investigation of design and bias issues in case-control studies of cancer screening using microsimulationR J Connor, R Boer, P C Prorok, et al.
Breast Cancer Research and Treatment|January 1, 1984
Possible immunological implications of an association between the stages of first and second independent breast cancersM M Black, B F Hankey, J L Aron, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Medical Screening|May 13, 1999
Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modificationP M Marcus, P C Prorok
Gynecologic Oncology|December 1, 1994
NIH Consensus 1994: screeningB S Kramer, J Gohagan, P C Prorok
Journal of Chronic Diseases|January 1, 1981
Concepts and problems in the evaluation of screening programsP C Prorok, B F Hankey, B N Bundy
Journal of Clinical Epidemiology|January 1, 1991
The case-control design and the assessment of the efficacy of cancer screeningR J Connor, P C Prorok, D L Weed
The Urologic Clinics of North America|November 1, 1990
Statistical considerations in cancer screening programsP C Prorok, R J Connor, S G Baker
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Is screening for prostate cancer the current gold standard?--"no"B S Kramer, J K Gohagan, P C Prorok
Statistics in Medicine|February 24, 1999
Estimation of post-lead-time survival under dependence between lead-time and post-lead-time survivalJ L Xu, R M Fagerstrom, P C Prorok
Cancer|January 15, 1993
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancersB S Kramer, J Gohagan, P C Prorok, et al.
American Journal of Epidemiology|June 15, 2000
Investigation of design and bias issues in case-control studies of cancer screening using microsimulationR J Connor, R Boer, P C Prorok, et al.
Breast Cancer Research and Treatment|January 1, 1984
Possible immunological implications of an association between the stages of first and second independent breast cancersM M Black, B F Hankey, J L Aron, et al.
Pageof 4